269 related articles for article (PubMed ID: 22930318)
1. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch?
Krause K; Krull C; Kessler B; Lange-Asschenfeldt B; Maurer M; Metz M
Acta Derm Venereol; 2013 Mar; 93(2):175-9. PubMed ID: 22930318
[TBL] [Abstract][Full Text] [Related]
2. Chronic hemicorporal prurigo related to a posttraumatic Brown-Séquard syndrome.
Thielen AM; Vokatch N; Borradori L
Dermatology; 2008; 217(1):45-7. PubMed ID: 18367840
[TBL] [Abstract][Full Text] [Related]
3. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
Tanis R; Ferenczi K; Payette M
J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review.
Almustafa ZZ; Weller K; Autenrieth J; Maurer M; Metz M
Acta Derm Venereol; 2019 Sep; 99(10):905-906. PubMed ID: 31233177
[No Abstract] [Full Text] [Related]
6. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
7. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
8. Treatment of prurigo nodularis with topical capsaicin.
Ständer S; Luger T; Metze D
J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
[TBL] [Abstract][Full Text] [Related]
9. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
[TBL] [Abstract][Full Text] [Related]
10. Prurigo simplex subacuta or prurigo simplex acuta?
Akar HH; Tahan F; Balkanli S; Sadet Özcan S
Eur Ann Allergy Clin Immunol; 2014 Jul; 46(4):152-3. PubMed ID: 25053633
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
12. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.
Saraceno R; Chiricozzi A; Nisticò SP; Tiberti S; Chimenti S
J Dermatolog Treat; 2010 Nov; 21(6):363-6. PubMed ID: 20536273
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone for the management of post-burn pruritus: A preliminary report.
LaSalle L; Rachelska G; Nedelec B
Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
[TBL] [Abstract][Full Text] [Related]
14. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
Meyer N; Paul C; Misery L
Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients.
Krull C; Schoepke N; Ohanyan T; Brachaczek M; Maurer M; Lange-Asschenfeldt B; Metz M
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1357-61. PubMed ID: 26446750
[TBL] [Abstract][Full Text] [Related]
16. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
[TBL] [Abstract][Full Text] [Related]
17. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
Maurer T; Poncelet A; Berger T
Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
Ameglio F; D'Auria L; Cordiali-Fei P; Mussi A; Valenzano L; D'Agosto G; Ferraro C; Bonifati C; Giacalone B
J Biol Regul Homeost Agents; 1997; 11(4):148-53. PubMed ID: 9582615
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Recalcitrant Prurigo with Alitretinoin.
Gadaldi K; Erdemoğlu Y; Yawalkar N
Dermatology; 2015; 231(4):330-3. PubMed ID: 26304762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
